Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-670P, RNA, U6 small nuclear 670, pseudogene, is a nonfunctional genomic segment related to the U6 small nuclear RNA gene. U6 snRNA is a vital spliceosomal RNA involved in mRNA splicing within the nucleus, but pseudogenes like RNU6-670P are typically noncoding and do not produce functional RNA molecules. Pseudogenes are generally silent genomic fossils, although in rare cases they may regulate gene expression through sequence homology-based mechanisms. There is no evidence or functional annotation suggesting that RNU6-670P has biological activity as a protein, enzyme, receptor, or therapeutic target[6][1][2]. Pseudogenes such as RNU6-670P arise from duplication or retrotransposition of functional genes (here, U6 snRNA) but lose the ability to code for active RNA or protein[6]. The functional counterpart, U6 small nuclear RNA (RNU6-1), is one of the core snRNAs in the spliceosome and is required for pre-mRNA splicing, which is central to eukaryotic gene expression[1][4]. Multiple nonfunctional copies (pseudogenes) of snRNA genes, including U6, exist in vertebrate genomes and typically serve no known biological function[1][6]. No evidence suggests RNU6-670P is therapeutically relevant or disease-associated, nor does it possess properties that make it a molecular target for drugs. If structured information for drug target databases is required, this entry should be flagged as incorrect or non-target.
None. No mechanism of action pertains to this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 670, pseudogene (RNU6-670P).